We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+8.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$69.6M
AUM Growth
-$2.49M
(-3.5%)
Cap. Flow
-$5.62M
Cap. Flow
% of AUM
-8.08%
Top 10 Holdings %
Top 10 Hldgs %
7.77%
Holding
455
New
196
Increased
39
Reduced
31
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$567K |
| 2 |
Monster Beverage
MNST
|
+$513K |
| 3 |
Western Union
WU
|
+$491K |
| 4 |
Equinix
EQIX
|
+$466K |
| 5 |
NSA
National Storage Affiliates Trust
NSA
|
+$447K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Navigator Holdings
NVGS
|
+$609K |
| 2 |
First Industrial Realty Trust
FR
|
+$577K |
| 3 |
Fidelity National Financial
FNF
|
+$565K |
| 4 |
Packaging Corp of America
PKG
|
+$564K |
| 5 |
WSR
Whitestone REIT
WSR
|
+$531K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.46% |
| 2 | Industrials | 15.47% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Financials | 12.89% |
| 5 | Real Estate | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Zebra Technologies
ZBRA
$12.4B
| – | – |
-1,338
| Closed | -$378K |
|
452
Zegna
ZGN
$3.84B
| – | – |
-18,254
| Closed | -$135K |
|
453
Zions Bancorporation
ZION
$10.1B
| – | – |
-6,864
| Closed | -$342K |
|
454
Rubrik
RBRK
$15.1B
| – | – |
-3,908
| Closed | -$238K |
|
|
ARDT
455
Ardent Health
ARDT
$1.53B
| – | – |
-13,642
| Closed | -$188K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
CCP
PharVision Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, PharVision Advisers held 455 positions worth $69.6M, down 3.5% from $72.1M the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
PharVision Advisers withdrew a net $5.62M in Q2 2025, closing 188 positions and reducing 31 holdings. Its most notable exit was Navigator Holdings, an estimated $609K position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, PharVision Advisers opened a new position in Clorox worth $510K.
- PharVision Advisers's largest Q2 2025 buy was Clorox: 4,249 shares worth $510K.
- PharVision Advisers added most to Meta Platforms (Facebook) in Q2 2025, an estimated $272K increase.
- PharVision Advisers's biggest Q2 2025 reduction was Global Ship Lease, cutting an estimated $369K.
- PharVision Advisers fully exited Navigator Holdings in Q2 2025, selling an estimated $609K.
- PharVision Advisers's ten largest holdings make up 7.8% of its $69.6M portfolio in Q2 2025.
- PharVision Advisers opened 196 new positions and closed 188 in Q2 2025.
- PharVision Advisers's portfolio value fell 3.5% quarter-over-quarter to $69.6M.
Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.